Patents by Inventor Mark Tykocinski

Mark Tykocinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120121640
    Abstract: Fusion proteins which act on the OX40/TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, and alloimmune diseases, as well as cancer.
    Type: Application
    Filed: March 11, 2010
    Publication date: May 17, 2012
    Inventor: Mark Tykocinski
  • Publication number: 20050096271
    Abstract: Novel fusion proteins comprising PP14 are disclosed. The fusion proteins retain the immunoregulatory function of native PP14, but offer significant advantages. Methods for using the fusion proteins, and sequence encoding the same in the treatment of immune system diseases and disorders are therefore also disclosed, as are methods for recombinant production of the present fusion proteins.
    Type: Application
    Filed: July 27, 2004
    Publication date: May 5, 2005
    Inventors: Mark Tykocinski, Gregory Riely